Exelixis Inc (NAS:EXEL)
$ 35.8372 -0.0128 (-0.04%) Market Cap: 10.23 Bil Enterprise Value: 9.22 Bil PE Ratio: 22.97 PB Ratio: 4.50 GF Score: 91/100

Q2 2023 Exelixis Inc Earnings Call Transcript

Aug 01, 2023 / 09:00PM GMT
Release Date Price: $19.63 (-0.41%)
Operator

Good day, ladies and gentlemen, and welcome to the Exelixis Second Quarter 2023 Financial Results Conference Call. My name is Towanda, and I will be your operator for today. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to your host for today, Ms. Susan Hubbard, Executive Vice President of Public Affairs and Investor Relations. You may begin.

Susan T. Hubbard
Exelixis, Inc. - EVP of Public Affairs & IR

Thank you, Towanda, and thank you all for joining us for the Exelixis Second Quarter 2023 Financial Results Conference Call. Joining me on today's call are Mike Morrissey, our President and CEO; Chris Senner, our Chief Financial Officer; P.J. Haley, our Executive Vice President of Commercial; Dana Aftab, our Chief Scientific Officer; and Vicki Goodman, our Chief Medical Officer, who will review our progress for the second quarter 2023 ended June 30, 2023. Peter Lamb, our EVP of Scientific Strategy will join us for the Q&A portion of the call.

During the call today, we will be making

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot